Clinicopath Conf
Demyelinating Disease, Case 8-1996, NEJM 334:715-720996., , 1996
Cerebrospinal Fluid in Acute Optic Neuritis:Experience of the Optic Neuritis Treatment Trial
Neurol 46:368-372, Rolak,L.A.,et al, 1996
Comparison of Triple Dose vs Std Dose Gadolinium-DTPA for Detect of MRI Enhanc Lesions in Pts with MS
Neurol 46:379-384, Filippi,M.,et al, 1996
Serial Gadolinium-Enhanced MRI of the Brain and Spinal Cord in Early Relapsing-Remitting MS
Neurol 46:373-378, Thorpe,J.W.,et al, 1996
A Special Form of Cerebral Lacunae:Expanding Lacunae
JNNP 61:200-202, Homeyer,P.,et al, 1996
Evidence for Genetic Basis of Multiple Sclerosis
Lancet 347:1728-1730, Sadovnick,A.D.,et al, 1996
Clinical and Subclinical Neurological Involvement in Children of Conjugal Multiple Sclerosis Patients
Multiple Sclerosis 1:170-172, Constantinescu,C.S.,et al, 1996
Conduction Aphasia in Multiple Sclerosis:A Case Report with MRI Findings
Neurol 47:576-578, Arnett,P.A.,et al, 1996
Multiple Sclerosis of the Spinal Cord:Magnetic Resonance Appearance
J Comput Assist Tomogr 20:434-438, Thielan,K.R.&Miller,G.M., 1996
Sporadic Corticosteroid Pulses and Osteoporosis in Multiple Sclerosis
Arch Neurol 53:753-757, Schwid,S.R.,et al, 1996
Treatment of Secondary Progressive Multiple Sclerosis with the Immunomodulator Linomide:Study with Monthly MRI Evaluation
Neurol 47:341-346, Karussis,D.M.,et al, 1996
Impact of Aerobic Training on Fitness and Quality of Life in Multiple Sclerosis
Ann Neurol 39:432-441, 4221996., Petajan,J.H.,et al, 1996
Risk of Cancer from Azathioprine Therapy in Multiple Sclerosis:A Case-Control Study
Neurol 46:1607-1612, Confavreux,C.,et al, 1996
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996
Subacute Leukoencephalitis Caused by CNS Infection with Human Herpesvirus-6 Manifesting as Acute Multiple Sclerosis
Neurol 47:145-148, Carrigan,D.R.,et al, 1996
Is Chronic Respiratory Failure in Neuromuscular Diseases Worth Treating
JNNP 61:1-3, Shneerson,J.M., 1996
Fatigue Therapy in Multiple Sclerosis:A Double-blind, Randomized, Parallel Trial of Amantadine, Pemoline & Placebo
Neurol 45:1956-1961, Krupp,L.B.,et al, 1995
Intractable Hiccups:The Role of Cerebral MR in Cases Without Systemic Cause
AJNR 16:2093-2100, Marsot-Dupuch,K.,et al, 1995
Comparison of Triple Dose vs Std Dose Gadolinium-DTPA for Detect of MRI Enhanc Lesions in Pts with Primary Progr MS
JNNP 59:540-544, Filippi,M.,et al, 1995
Cerebrospinal Fluid
JNNP 59:349-357, Thompson,E.J., 1995
The Effect of Gadolinium on the Sensitivity and Specificity of MR in the Initial Diagnosis of Multiple Sclerosis
AJNR 16:259-264, Tas,M.W.,et al, 1995
Unusual Widening of Virchow-Robin Spaces:MR Appearance
AJNR 16:1238-1242, Ogawa,T.,et al, 1995
Neurofibromatosis 1 and Multiple Sclerosis
JNNP 58:582-585, Ferner,R.E.,et al, 1995
Infraputaminal'Lacunes':Clinical and Pathological Correlations
Stroke 26:1598-1602, Pullicino,P.M.,et al, 1995
Multiple Sclerosis in the Spinal Cord, MR Appearance and Correlation with Clinical Parameters
Radiology 195:725-732, Tartaglino,L.M.,et al, 1995
Interferon Beta-1b in the Trtm of MS:Outcome of the Randomized Controlled Trial
IFNB Study Gr, Neurol 45:1277-12851995., , 1995
Effect of Interferon-B on Blood-Brain Barrier Disrupt Demonst by Contrast MRI in Relapsing-Remitting MS
Ann Neurol 37:611-619, Stone,L.A.,et al, 1995
Copolymer 1 Reduces Relapse Rate & Improves Disability in Relapsing-Remitting MS:Multictr Trial
Neurol 45:1268-1276, Johnson,K.P.,et al, 1995
Trigeminal Neuralgia in Multiple Sclerosis
Neurol 45:1294-1296, Hooge,J.P.&Redekop,W.K., 1995
Association Between Trigeminal Neuralgia and Multiple Sclerosis:Role of Magnetic Resonance Imaging
JNNP 59:253-259, Meaney,J.F.M.,et al, 1995
Measuring Patient-Centered Outcomes in Neurologic Disease, Extending the Q-TWIST Method
Arch Neurol 52:754-762, Schwartz,C.,et al, 1995
Tumoral Multiple Sclerosis of the Cerebellum in a Child
AJNR 16:1164-1166, Rusin,J.A.,et al, 1995
Clinical, Neurodiagnostic, and MR Findings in Children with Spinal & Brain Stem Multiple Sclerosis
AJNR 16:87-95, Glasier,C.M.,et al, 1995
The Interferons:Biological Effects, Mechanisms of Action, and Use in Multiple Sclerosis
Ann Neurol 37:7-15, Weinstock-Guttman,B.,et al, 1995
New Treatments for Multiple Sclerosis
BMJ 310:345-346, McDonald,W.I., 1995
Frequency of Anti-Nuclear Antibodies in Multiple Sclerosis
Neurol 45:384-385, Barned,S.,et al, 1995
Low-Dose (7. 5mg) Oral Methotrexate Reduces the Rate of Progression in Chronic Progressive Multiple Sclerosis
Ann Nuerol 37:30-40, 51995., Goodkin,D.E.,et al, 1995
Neurologic Aspects of Inflammatory Bowel Disease
Neurol 45:416-421, Lossos,A.,et al, 1995
Bilateral Simultaneous Optic Neuropathy in Adults:Clinical, Imaging, Serological, and Genetic Studies
JNNP 58:70-74, Morrissey,S.P.,et al, 1995
Optic Neuritis:A Population-Based Study in Olmsted County, Minnesota
Neurol 45:244-250, Rodriquez,M.,et al, 1995
Correlation Between Changes in Disability and T2-Weighted Brain MRI Activity in Multiple Sclerosis:A Follow-up Study
Neurol 45:255-260, Filippi,M.,et al, 1995
Acute Transverse Myelopathy:Spinal and Cranial MR Study with Clinical Follow-up
AJNR 16:115-123, Campi,A.,et al, 1995
Focal Leptomeningeal MR Enhancement Along the Chiasm as a Presenting Sign of Multiple Sclerosis
J Comput Assist Tomogr 19:297-298, Demaerel,Ph.,et al, 1995
Magnetic Resonance Imaging of Brain Iron in Health and Disease
J Neurol Sci 134:19-26,1, Vymazal,J.,et al, 1995
Spinal Multiple Sclerosis Mimicking a Spinal Cord Tumor:A Case Report
Neurological Surgery 23:1007-1010, Maezawa,H.,et al, 1995
Patients with Multiple Sclerosis Presenting to Psychiatric Hospitals
J Clin Psychiatry 56:297-306, Pine,D.S.,et al, 1995
Movement Disorders Following Lesions of the Thalamus or Subthalamic Region
Mov Disord 9:493-507, Lee,M.S. &Marsden, C.D., 1994
Tizanidine Treatment of Spasticity Caused by Multiple Sclerosis:Results of a Double-Blinded, Placebo-Controlled Trial
Neurol 44:S34-S43, Smith,C.,et al, 1994
A Double-Blind, Placebo-Controlled Trial of Tizanidine in the Treatment of Spasticity Caused by Multiple Sclerosis
Neurol 44:S70-S78, Barnes,M.P.,et al, 1994
Growth Factors:Potential Therapeutic Applications in Neurology
JNNP 54:1445-1450, Drago,J.,et al, 1994